- Neurogenic Mechanism – PT-141 (Bremelanotide) is a synthetic analog of α-MSH (alpha-melanocyte stimulating hormone) acting on melanocortin receptors MC3R and MC4R in the hypothalamus, studied for its potential neuromodulatory effects on sexual behavior.
- Sexual Arousal Research – Investigated for enhancing libido and arousal through central nervous system pathways rather than peripheral vascular action, making it distinct from PDE5 inhibitors.
- Potential Gender Applications – Research explores its efficacy in both male and female sexual dysfunction models, including hypoactive sexual desire disorder (HSDD).
- CNS Modulation – May influence dopaminergic signaling, mood, and stress response through its melanocortin receptor interaction.
- Synergistic Studies – Often studied in combination with peptides like Kisspeptin-10 and Oxytocin for understanding complex neuroendocrine modulation of desire and social bonding.
- Pharmacokinetic Insights – Exhibits rapid absorption and dose-dependent plasma exposure, making it useful in short-term behavioral research models.
